Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible

BACKGROUND: Brain metastases (BMs) are common in melanoma patients. Adjuvant whole brain radiotherapy (WBRT) following local treatment of intracranial melanoma metastases with neurosurgery and/or stereotactic radiosurgery is controversial. A randomised trial is needed. However, accrual to WBRT trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Fogarty, Gerald B, Hong, Angela, Jacobsen, Kari Dolven, Reisse, Claudius H, Shivalingam, Brindha, Burmeister, Bryan, Haydu, Lauren E, Paton, Elizabeth, Thompson, John F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083364/
https://www.ncbi.nlm.nih.gov/pubmed/24981506
http://dx.doi.org/10.1186/1756-0500-7-412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083364/
https://www.ncbi.nlm.nih.gov/pubmed/24981506
http://dx.doi.org/10.1186/1756-0500-7-412

Ejemplares similares